HLB Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017
Period Ending	Jul '25 Jul 17, 2025	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Market Capitalization	257,816	75,194	58,507	80,206
Market Cap Growth	28.52%	28.52%	-27.05%	-
Enterprise Value	-	77,595	62,071	-
Last Close Price	18360.00	5430.00	4225.00	6420.00
PE Ratio	545.46	159.09	-	-
PS Ratio	7.14	2.08	2.85	5.16
PB Ratio	14.40	4.20	3.44	4.77
P/TBV Ratio	14.77	4.31	3.50	4.83
P/OCF Ratio	190.51	55.56	-	-
EV/Sales Ratio	-	2.15	3.02	-
EV/EBITDA Ratio	-	25.19	-	-
EV/EBIT Ratio	-	53.85	-	-
Debt / Equity Ratio	0.74	0.74	0.45	0.89
Debt / EBITDA Ratio	4.28	4.28	-	-
Asset Turnover	0.88	0.88	0.54	-
Inventory Turnover	3.27	3.27	3.13	-
Quick Ratio	1.01	1.01	0.94	1.01
Current Ratio	1.26	1.26	1.31	1.31
Return on Equity (ROE)	2.71%	2.71%	-41.77%	-
Return on Assets (ROA)	2.19%	2.19%	-9.55%	-
Return on Capital (ROIC)	3.23%	3.23%	-12.90%	-
Return on Capital Employed (ROCE)	6.30%	6.30%	-	-
Earnings Yield	0.18%	0.63%	-12.07%	-6.79%
FCF Yield	-0.02%	-0.06%	-4.91%	-3.77%
Buyback Yield / Dilution	-2.30%	-2.30%	-13.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.